Sarissa Capital Domestic Fund LP is 10% at APRICUS BIOSCIENCES, INC. (APRI). They have made 1 open-market trade across 1 company since 2017, most recently 2017-08-31.
CIK 0001575277
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APRI | 1,447,906 | $319K |
Shares reported on the most recent Form 4, priced at the 2017-09-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APRI | BUY | 2017-08-31 | 2017-09-01 | $1.63 | $10K | +12.8% | +14.7% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.